Browse by Audience
Skip to content
Papers of the Week
Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn’s disease.
Authors
Abstract
Crohn's disease (CD) is a chronic inflammatory disorder that can involve any part of the gastrointestinal tract. 5-Aminosalicylates (5-ASAs) are locally acting, anti-inflammatory compounds that reduce inflammation of the colonic mucosa with release profiles that vary among various commercially available formulations. This updated Cochrane review summarizes current evidence on the use of 5-ASA formulations for maintenance of surgically-induced remission in CD.